Glucose Transporters Are Key Components of the Human Glucostat
Diabetes · 01.08.2024 · 73 (8) · 1336-1351
DOI: 10.2337/db23-0508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, online erschienen am 22.05.2024. Verfasst von Inbal Caspi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY. Hauptthemen laut MEDLINE: Glucose Transporter Type 2, Glucose Transporter Type 1, Insulin-Secreting Cells. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Diabetes Association, Wisconsin Alumni Research Foundation, PRMRP.
Abstract (Originalsprache)
Mouse models are extensively used in metabolic studies. However, inherent differences between the species, notably their blood glucose levels, hampered data translation into clinical settings. In this study, we confirmed GLUT1 to be the predominantly expressed glucose transporter in both adult and fetal human β-cells. In comparison, GLUT2 is detected in a small yet significant subpopulation of adult β-cells and is expressed to a greater extent in fetal β-cells. Notably, GLUT1/2 expression in INS+ cells from human stem cell-derived islet-like clusters (SC-islets) exhibited a closer resemblance to that observed in fetal islets. Transplantation of primary human islets or SC-islets, but not murine islets, lowered murine blood glucose to the human glycemic range, emphasizing the critical role of β-cells in establishing species-specific glycemia. We further demonstrate the functional requirements of GLUT1 and GLUT2 in glucose uptake and insulin secretion through chemically inhibiting GLUT1 in primary islets and SC-islets and genetically disrupting GLUT2 in SC-islets. Finally, we developed a mathematical model to predict changes in glucose uptake and insulin secretion as a function of GLUT1/2 expression. Collectively, our findings illustrate the crucial roles of GLUTs in human β-cells, and identify them as key components in establishing species-specific glycemic set points. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Weill Cornell Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY.
- Developmental Biology Program, Sloan Kettering Institute, New York, NY.
- Transplantation Division, Department of Surgery, University of Wisconsin-Madison, Madison, WI.
- Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan-Kettering Cancer Center, New York, NY.
ORCID-Profile: Danwei Huangfu
Förderung
- American Diabetes Association
- Wisconsin Alumni Research Foundation
- PRMRP
- Breakthrough T1D
- Center for Stem Cell Biology of the Sloan Kettering Institute
- NIH HHS
- the University of Wisconsin-Madison, Office of the Vice Chancellor for Research
- NIDDK NIH HHS
Zitieren
APA
Caspi, I., Tremmel, D. M., Pulecio, J., Yang, D., Liu, D., Yan, J., Odorico, J. S., & Huangfu, D. (2024). Glucose Transporters Are Key Components of the Human Glucostat. Diabetes, 73(8), 1336-1351. https://doi.org/10.2337/db23-0508
Vancouver
Caspi I, Tremmel DM, Pulecio J, Yang D, Liu D, Yan J, et al. Glucose Transporters Are Key Components of the Human Glucostat. Diabetes. 2024;73(8):1336-1351. doi:10.2337/db23-0508
BibTeX
@article{Caspi2024,
author = {Caspi, Inbal and Tremmel, Daniel M and Pulecio, Julian and Yang, Dapeng and Liu, Dingyu and Yan, Jielin and Odorico, Jon S and Huangfu, Danwei},
title = {Glucose Transporters Are Key Components of the Human Glucostat},
journal = {Diabetes},
year = {2024},
volume = {73},
number = {8},
pages = {1336--1351},
doi = {10.2337/db23-0508}
}
EUVIMED